Novavax stock falls 20% as vaccine maker misses quarterly estimates, sees sluggish 2024 sales

(CNBC) Shares of Novavax closed more than 20% lower on Wednesday after the vaccine maker reported fourth-quarter revenue and earnings that missed Wall Street’s estimates and said it expects full-year 2024 sales to come in flat or lower than last year.

To read this article:

This entry was posted in Syndicated. Bookmark the permalink.

Comments are closed.